Views: 810
HYDERABAD: A week after Bharat Biotech and Indian Council of Medical Research (ICMR) introduced that India’s first indigenous Covid-19 vaccine Covaxin, (codenamed BBV152) has proven a meantime efficacy of almost 81%, prestigious clinical magazine The Lancet has now posted Phase 2 medical trial outcomes of the vaccine candidate. The outcomes […]